Merck: New indication for Singulair approved to prevent exercise-induced Bronchoconstriction

Wed Apr 25, 2007 8:45am EDT
 
[-] Text [+]
Co announces that the FDA has approved a new indication for Singulair to prevent exercise-induced bronchoconstriction (EIB; also known as exercise-induced asthma) in patients aged 15 years and older. Singulair is the first and only oral tablet approved for this use.

 

Featured Broker sponsored link

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video